CURE Pharmaceutical Q3 Revenue Grows 58.9% Sequentially To $1.8M
CURE Pharmaceutical Holding Corp. (OTCQB: CURR) revenue in the third quarter increased 32.1% year-over-year and 58.9% sequentially from Q2 2022 to $1.8 million.
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
All news is property of their respective owners.
